| Year |
Citation |
Score |
| 2020 |
Imamoto A, Ki S, Li L, Iwamoto K, Maruthamuthu V, Devany J, Lu O, Kanazawa T, Zhang S, Yamada T, Hirayama A, Fukuda S, Suzuki Y, Okada M. Essential role of the family-dosage in DiGeorge-like anomaly and metabolic homeostasis. Life Science Alliance. 3. PMID 32041892 DOI: 10.26508/lsa.201900635 |
0.349 |
|
| 2017 |
Haller M, Mo Q, Imamoto A, Lamb DJ. Murine model indicates 22q11.2 signaling adaptor CRKL is a dosage-sensitive regulator of genitourinary development. Proceedings of the National Academy of Sciences of the United States of America. PMID 28439006 DOI: 10.1073/Pnas.1619523114 |
0.432 |
|
| 2016 |
Shigeno-Nakazawa Y, Kasai T, Ki S, Kostyanovskaya E, Pawlak J, Yamagishi J, Okimoto N, Taiji M, Okada M, Westbrook J, Satta Y, Kigawa T, Imamoto A. A pre-metazoan origin of the CRK gene family and co-opted signaling network. Scientific Reports. 6: 34349. PMID 27686861 DOI: 10.1038/Srep34349 |
0.404 |
|
| 2013 |
Zeng L, Ehrenreiter K, Menon J, Menard R, Kern F, Nakazawa Y, Bevilacqua E, Imamoto A, Baccarini M, Rosner MR. RKIP regulates MAP kinase signaling in cells with defective B-Raf activity. Cellular Signalling. 25: 1156-65. PMID 23416466 DOI: 10.1016/J.Cellsig.2013.02.005 |
0.497 |
|
| 2013 |
Yamagishi J, Okimoto N, Kasai T, Suenaga A, Okada M, Imamoto A, Taiji M. 1P043 Computational design of short peptide inhibitors of protein-protein interactions in intracellular signaling mediated by CRK-SH2(01B. Protein:Structure & Function,Poster) Seibutsu Butsuri. 53. DOI: 10.2142/Biophys.53.S113_1 |
0.322 |
|
| 2010 |
Seo JH, Wood LJ, Agarwal A, O'Hare T, Elsea CR, Griswold IJ, Deininger MW, Imamoto A, Druker BJ. A specific need for CRKL in p210BCR-ABL-induced transformation of mouse hematopoietic progenitors. Cancer Research. 70: 7325-35. PMID 20807813 DOI: 10.1158/0008-5472.Can-10-0607 |
0.389 |
|
| 2009 |
Shemon AN, Eves EM, Clark MC, Heil G, Granovsky A, Zeng L, Imamoto A, Koide S, Rosner MR. Raf Kinase Inhibitory Protein protects cells against locostatin-mediated inhibition of migration. Plos One. 4: e6028. PMID 19551145 DOI: 10.1371/Journal.Pone.0006028 |
0.483 |
|
| 2009 |
Seo JH, Suenaga A, Hatakeyama M, Taiji M, Imamoto A. Structural and functional basis of a role for CRKL in a fibroblast growth factor 8-induced feed-forward loop. Molecular and Cellular Biology. 29: 3076-87. PMID 19307307 DOI: 10.1128/Mcb.01686-08 |
0.419 |
|
| 2008 |
Zeng L, Imamoto A, Rosner MR. Raf kinase inhibitory protein (RKIP): a physiological regulator and future therapeutic target. Expert Opinion On Therapeutic Targets. 12: 1275-87. PMID 18781826 DOI: 10.1517/14728222.12.10.1275 |
0.442 |
|
| 2006 |
Zhu F, Choi BY, Ma WY, Zhao Z, Zhang Y, Cho YY, Choi HS, Imamoto A, Bode AM, Dong Z. COOH-terminal Src kinase-mediated c-Jun phosphorylation promotes c-Jun degradation and inhibits cell transformation. Cancer Research. 66: 5729-36. PMID 16740711 DOI: 10.1158/0008-5472.Can-05-4466 |
0.41 |
|
| 2006 |
Lee BC, Avraham S, Imamoto A, Avraham HK. Identification of the nonreceptor tyrosine kinase MATK/CHK as an essential regulator of immune cells using Matk/CHK-deficient mice. Blood. 108: 904-7. PMID 16574955 DOI: 10.1182/Blood-2005-12-4885 |
0.45 |
|
| 2006 |
Guris DL, Duester G, Papaioannou VE, Imamoto A. Dose-dependent interaction of Tbx1 and Crkl and locally aberrant RA signaling in a model of del22q11 syndrome. Developmental Cell. 10: 81-92. PMID 16399080 DOI: 10.1016/J.Devcel.2005.12.002 |
0.302 |
|
| 2006 |
Moon AM, Guris DL, Seo JH, Li L, Hammond J, Talbot A, Imamoto A. Crkl deficiency disrupts Fgf8 signaling in a mouse model of 22q11 deletion syndromes. Developmental Cell. 10: 71-80. PMID 16399079 DOI: 10.1016/J.Devcel.2005.12.003 |
0.417 |
|
| 2004 |
Ballif BA, Arnaud L, Arthur WT, Guris D, Imamoto A, Cooper JA. Activation of a Dab1/CrkL/C3G/Rap1 pathway in Reelin-stimulated neurons. Current Biology : Cb. 14: 606-10. PMID 15062102 DOI: 10.1016/J.Cub.2004.03.038 |
0.432 |
|
| 2004 |
Duan LJ, Imamoto A, Fong GH. Dual roles of the C-terminal Src kinase (Csk) during developmental vascularization. Blood. 103: 1370-2. PMID 14576066 DOI: 10.1182/Blood-2003-05-1701 |
0.409 |
|
| 2003 |
Peterson AC, Marks RE, Fields PE, Imamoto A, Gajewski TF. T cell development and function in CrkL-deficient mice. European Journal of Immunology. 33: 2687-95. PMID 14515252 DOI: 10.1002/Eji.200324294 |
0.354 |
|
| 2003 |
Li L, Guris DL, Okura M, Imamoto A. Translocation of CrkL to focal adhesions mediates integrin-induced migration downstream of Src family kinases. Molecular and Cellular Biology. 23: 2883-92. PMID 12665586 DOI: 10.1128/Mcb.23.8.2883-2892.2003 |
0.441 |
|
| 2002 |
Lekmine F, Sassano A, Uddin S, Majchrzak B, Miura O, Druker BJ, Fish EN, Imamoto A, Platanias LC. The CrkL adapter protein is required for type I interferon-dependent gene transcription and activation of the small G-protein Rap1. Biochemical and Biophysical Research Communications. 291: 744-50. PMID 11866427 DOI: 10.1006/Bbrc.2002.6516 |
0.466 |
|
| 2002 |
Li L, Okura M, Imamoto A. Focal adhesions require catalytic activity of Src family kinases to mediate integrin-matrix adhesion. Molecular and Cellular Biology. 22: 1203-17. PMID 11809811 DOI: 10.1128/Mcb.22.4.1203-1217.2002 |
0.457 |
|
| 2002 |
Hagel M, George EL, Kim A, Tamimi R, Opitz SL, Turner CE, Imamoto A, Thomas SM. The adaptor protein paxillin is essential for normal development in the mouse and is a critical transducer of fibronectin signaling. Molecular and Cellular Biology. 22: 901-15. PMID 11784865 DOI: 10.1128/Mcb.22.3.901-915.2002 |
0.665 |
|
| 2001 |
Guris DL, Fantes J, Tara D, Druker BJ, Imamoto A. Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome. Nature Genetics. 27: 293-8. PMID 11242111 DOI: 10.1038/85855 |
0.384 |
|
| 2000 |
Dey A, She H, Kim L, Boruch A, Guris DL, Carlberg K, Sebti SM, Woodley DT, Imamoto A, Li W. Colony-stimulating factor-1 receptor utilizes multiple signaling pathways to induce cyclin D2 expression Molecular Biology of the Cell. 11: 3835-3848. PMID 11071910 DOI: 10.1091/Mbc.11.11.3835 |
0.389 |
|
| 1998 |
Tsuda M, Matozaki T, Fukunaga K, Fujioka Y, Imamoto A, Noguchi T, Takada T, Yamao T, Takeda H, Ochi F, Yamamoto T, Kasuga M. Integrin-mediated Tyrosine Phosphorylation of SHPS-1 and Its Association with SHP-2 ROLES OF Fak AND Src FAMILY KINASES Journal of Biological Chemistry. 273: 13223-13229. PMID 9582366 DOI: 10.1074/Jbc.273.21.13223 |
0.482 |
|
| 1997 |
Zambrowicz BP, Imamoto A, Fiering S, Herzenberg LA, Kerr WG, Soriano P. Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. Proceedings of the National Academy of Sciences of the United States of America. 94: 3789-94. PMID 9108056 DOI: 10.1073/Pnas.94.8.3789 |
0.602 |
|
| 1995 |
Thomas SM, Soriano P, Imamoto A. Specific and redundant roles of Src and Fyn in organizing the cytoskeleton Nature. 376: 267-271. PMID 7617039 DOI: 10.1038/376267A0 |
0.669 |
|
| 1994 |
Imamoto A, Soriano P, Stein PL. Genetics of signal transduction: tales from the mouse. Current Opinion in Genetics & Development. 4: 40-6. PMID 8193538 DOI: 10.1016/0959-437X(94)90089-2 |
0.535 |
|
| 1993 |
Imamoto A, Wang XJ, Fujiki H, Walker SE, Beltrán LM, DiGiovanni J. Comparison of 12-O-tetradecanoylphorbol-13-acetate and teleocidin for induction of epidermal hyperplasia, activation of epidermal PKC isozymes and skin tumor promotion in SENCAR and C57BL/6 mice. Carcinogenesis. 14: 719-24. PMID 8472338 DOI: 10.1093/Carcin/14.4.719 |
0.328 |
|
| 1993 |
Imamoto A, Soriano P. Disruption of the csk gene, encoding a negative regulator of Src family tyrosine kinases, leads to neural tube defects and embryonic lethality in mice. Cell. 73: 1117-24. PMID 7685657 DOI: 10.1016/0092-8674(93)90641-3 |
0.632 |
|
| 1992 |
Imamoto A, Beltrán LM, Fujiki H, Chenicek KJ, DiGiovanni J. Enhanced induction of epidermal ornithine decarboxylase activity in C57BL/6 compared to DBA/2 mice by protein kinase C-activating skin tumor promoters: relevance to genetically mediated differences in promotion susceptibility. Carcinogenesis. 13: 177-82. PMID 1740006 DOI: 10.1093/Carcin/13.2.177 |
0.372 |
|
| 1992 |
DiGiovanni J, Imamoto A, Naito M, Walker SE, Beltrán L, Chenicek KJ, Skow L. Further genetic analyses of skin tumor promoter susceptibility using inbred and recombinant inbred mice. Carcinogenesis. 13: 525-31. PMID 1576703 DOI: 10.1093/Carcin/13.4.525 |
0.306 |
|
| 1991 |
Imamoto A, Beltrán LM, DiGiovanni J. Evidence for autocrine/paracrine growth stimulation by transforming growth factor-alpha during the process of skin tumor promotion. Molecular Carcinogenesis. 4: 52-60. PMID 2009135 DOI: 10.1002/Mc.2940040109 |
0.306 |
|
| 1990 |
Imamoto A, Beltrán LM, DiGiovanni J. Differential mechanism for the inhibition of epidermal growth factor binding to its receptor on mouse keratinocytes by anthrones and phorbol esters. Carcinogenesis. 11: 1543-9. PMID 2401043 DOI: 10.1093/Carcin/11.9.1543 |
0.345 |
|
| Show low-probability matches. |